Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 3/2012

01-09-2012 | Brief Communication

Hepatocellular Carcinoma Presenting as an Incidental Isolated Malignant Portal Vein Thrombosis

Authors: Nishant Poddar, Boris Avezbakiyev, Zili He, Ming Jiang, Arash Gohari, Jen Chen Wang

Published in: Journal of Gastrointestinal Cancer | Issue 3/2012

Login to get access

Abstract

Introduction

Portal vein thrombosis is frequently associated with hepatocellular carcinoma (HCC). Tumor invasion into the portal vein by direct venous extension or metastasis occurs in up to 70% of HCC patients (Cedrone et al., Liver 16:94–8, 1996). However, presentation as an isolated malignant portal vein thrombosis without any evidence of obvious hepatoma-like lesions in the liver by imaging studies is extremely uncommon. We present an unusual case of HCC presenting as a malignant portal vein thrombus, proven on biopsy of the thrombus without any evidence of primary liver lesion. This, to our knowledge, is the first case of HCC presenting as an incidental isolated malignant portal vein thrombosis. The importance of doing delayed enhancement imaging studies to rule out malignant portal vein thrombosis is emphasized.

Case Report

A 60-year-old man presented with acute substernal chest pain. Physical examination revealed icterus. Examination of the abdomen did not reveal any organomegaly. Liver function test revealed a predominantly conjugated bilirubinemia. Abdominal sonogram revealed thrombosis and occlusion of the posterior right portal vein. Liver parenchyma was homogenous with no intrahepatic mass. Computed tomography (CT) of the abdomen and pelvis after administration of oral and intravenous contrast with delayed views revealed arterial enhancement of the right portal vein thrombus with delayed washout. MRI of the abdomen with gadolinium confirmed the right portal vein thrombus without focal hepatic mass. Aspiration of the right portal vein thrombus under CT guidance revealed hepatocellular carcinoma which was confirmed by immunohistochemistry. Serum alpha-fetoprotein level was very high. Patient was started on sorafenib with subsequent decrease in alpha-fetoprotein level. He was doing well till the date of this report.

Discussion

This unusual case of hepatocellular carcinoma presenting as an incidental malignant portal vein thrombosis without any primary liver lesion is extremely rare. Other reported cases of malignant portal vein thrombosis have been in patients with underlying hepatoma, cirrhosis, or with intrabiliary hepatocelluar carcinoma. In the clinical setting of portal vein thrombosis, imaging studies showing enhancement of the thrombus in the arterial phase are important in leading to the diagnosis of malignancy.
Literature
1.
go back to reference Cedrone A, Rapaccini GL, Pompili M, Aliotta A, Trombino C, De Luca F, et al. Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in therapeutic management. Liver. 1996;16:94–8.PubMed Cedrone A, Rapaccini GL, Pompili M, Aliotta A, Trombino C, De Luca F, et al. Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in therapeutic management. Liver. 1996;16:94–8.PubMed
2.
go back to reference Di Bisceglie AM, Carithers Jr RL, Gores GJ. Hepatocellular carcinoma. Hepatology. 1998;28(4):1161–5.PubMedCrossRef Di Bisceglie AM, Carithers Jr RL, Gores GJ. Hepatocellular carcinoma. Hepatology. 1998;28(4):1161–5.PubMedCrossRef
3.
go back to reference Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27(9):1485–91.PubMedCrossRef Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27(9):1485–91.PubMedCrossRef
4.
go back to reference El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–50.PubMedCrossRef El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–50.PubMedCrossRef
5.
go back to reference Benvegnù L, Fattovich G, Noventa F, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer. 1994;74(9):2442–8.PubMedCrossRef Benvegnù L, Fattovich G, Noventa F, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer. 1994;74(9):2442–8.PubMedCrossRef
6.
go back to reference Chiaramonte M, Stroffolini T, Vian A, et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer. 1999;85(10):2132–7.PubMedCrossRef Chiaramonte M, Stroffolini T, Vian A, et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer. 1999;85(10):2132–7.PubMedCrossRef
7.
go back to reference Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 1993;18(1):47–53.PubMedCrossRef Ikeda K, Saitoh S, Koida I, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 1993;18(1):47–53.PubMedCrossRef
8.
go back to reference Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988;61(10):1942–56.PubMedCrossRef Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988;61(10):1942–56.PubMedCrossRef
9.
go back to reference Bruix J, Barrera JM, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989;2(8670):1004–6.PubMedCrossRef Bruix J, Barrera JM, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989;2(8670):1004–6.PubMedCrossRef
10.
go back to reference Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993;328(25):1797–801.PubMedCrossRef Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993;328(25):1797–801.PubMedCrossRef
11.
go back to reference Connolly GC, Chen R, Hyrien O, Mantry P, Bozorgzadeh A, Abt P, et al. Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb. 2008;122(3):299–306. Epub 2007 Nov 28.CrossRef Connolly GC, Chen R, Hyrien O, Mantry P, Bozorgzadeh A, Abt P, et al. Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb. 2008;122(3):299–306. Epub 2007 Nov 28.CrossRef
12.
go back to reference Oliver 3rd JH, Baron RL, Federle MP, Rockette Jr HE. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR Am J Roentgenol. 1996;167:71–7.PubMed Oliver 3rd JH, Baron RL, Federle MP, Rockette Jr HE. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR Am J Roentgenol. 1996;167:71–7.PubMed
13.
go back to reference Yamshita Y, Mitsuzaki K, Yi T, et al. Small hepatocellular carcinoma in patient with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology. 1996;200:79–84. Yamshita Y, Mitsuzaki K, Yi T, et al. Small hepatocellular carcinoma in patient with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology. 1996;200:79–84.
14.
go back to reference Lai R, Stephens V, Bardales R. Diagnosis and staging of hepatocellular carcinoma by EUS-FNA of a portal vein thrombus. Gastrointest Endosc. 2004;59(4):574–7.PubMedCrossRef Lai R, Stephens V, Bardales R. Diagnosis and staging of hepatocellular carcinoma by EUS-FNA of a portal vein thrombus. Gastrointest Endosc. 2004;59(4):574–7.PubMedCrossRef
15.
go back to reference Tomemori T, Yamakado K, Nakatsuka A, Sakuma H, Matsumura K, Takeda K. Fast 3D dynamic MR imaging of the liver with MR SmartPrep: comparison with helical CT in detecting hypervascular hepatocellular carcinoma. Clin Imaging. 2001;25(5):355–61.PubMedCrossRef Tomemori T, Yamakado K, Nakatsuka A, Sakuma H, Matsumura K, Takeda K. Fast 3D dynamic MR imaging of the liver with MR SmartPrep: comparison with helical CT in detecting hypervascular hepatocellular carcinoma. Clin Imaging. 2001;25(5):355–61.PubMedCrossRef
16.
go back to reference Subba RD, Dushyant VS, Sanjay S. MRI in detection of hepatocellular carcinoma (HCC). Cancer Imaging. 2005;5:20–4.CrossRef Subba RD, Dushyant VS, Sanjay S. MRI in detection of hepatocellular carcinoma (HCC). Cancer Imaging. 2005;5:20–4.CrossRef
17.
go back to reference Adeyanju MO, Dodd GD, Madariaga JR, Dekker A. Ultrasonically guided fine-needle aspiration biopsy of portal vein thrombosis: a cytomorphological study of 14 patients. Diagn Cytopathol. 1994;11(3):281–5.PubMedCrossRef Adeyanju MO, Dodd GD, Madariaga JR, Dekker A. Ultrasonically guided fine-needle aspiration biopsy of portal vein thrombosis: a cytomorphological study of 14 patients. Diagn Cytopathol. 1994;11(3):281–5.PubMedCrossRef
18.
go back to reference Diaz-Ruiz MJ, Falcó J, Martin J, Bella RM, Carrasco M, Tortajada L. Hepatocellular carcinoma presenting as portal thrombosis with intrabiliary growth: US and MR findings. Abdom Imaging. 2000;25(3):263–5.PubMedCrossRef Diaz-Ruiz MJ, Falcó J, Martin J, Bella RM, Carrasco M, Tortajada L. Hepatocellular carcinoma presenting as portal thrombosis with intrabiliary growth: US and MR findings. Abdom Imaging. 2000;25(3):263–5.PubMedCrossRef
Metadata
Title
Hepatocellular Carcinoma Presenting as an Incidental Isolated Malignant Portal Vein Thrombosis
Authors
Nishant Poddar
Boris Avezbakiyev
Zili He
Ming Jiang
Arash Gohari
Jen Chen Wang
Publication date
01-09-2012
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 3/2012
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-010-9235-z

Other articles of this Issue 3/2012

Journal of Gastrointestinal Cancer 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.